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INTRODUCTION:  We  encountered  a rare case  of  tubular  adenoma  developing  after  bladder  augmentation.
We here report  our case  as well  as  summarize  reports  in  the  literature  on  adenomas  developing  after
bladder  augmentation.
PRESENTATION  OF  CASE:  A 23-year-old  man  came  to  our  hospital  for routine  surveillance  cystoscopy.
He  was  born  with  a lipomyelomeningocele  and  neurogenic  bladder  with  low bladder  compliance,  and
hence  his  bladder  was  routinely  emptied  by  clean  intermittent  catheterization.  He  was  also  treated  with
anticholinergic  agents.  However,  because  the patient’s  neurogenic  bladder  was  unstable,  he  underwent
sigmoidocolocystoplasty  when  he was  8-years  old.  After  the bladder  augmentation,  he  was  examined
annually  by  surveillance  cystoscopy.
On cystoscopy,  a 5-mm pedunculated  polyp  was  found  on the  front  side  of  the  sigmoid  colon  cap.  There-
fore,  we performed  snare  polypectomy  together  with  electrocoagulation  under  cystoscopy.  The patient’s
ﬁnal  diagnosis  was tubular  adenoma  (mild  atypia)  with  no  malignancy,  as  assessed  by  histopathology.
There has  been  no  evidence  of  recurrence  after  the  polypectomy  on  routine  surveillance  cystoscopy.
DISCUSSION:  To  the  best  of  our  knowledge,  there  have  been  11 cases  of adenoma  occurring  after  bladder
augmentation  reported  in the  literature,  including  our  present  case.  There  are several  carcinogenic  path-
ways associated  with  colorectal  oncogenesis.  Adenomas  that  are  larger  than  1.0  cm in  diameter  with  a
marked villous  component  have  a high  risk  of  oncogenesis.
CONCLUSION:  We  believe  that the early  detection  of  carcinoma  or adenoma  and  their treatment  at  an
early  stage  is crucial.  Therefore,  we  recommend  routine  surveillance  cystoscopy  for patients  after  bladder
augmentation.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
This work has been reported in line with the CARE criteria
1]. Enterocystoplasty (ECP) using the colon, ileum, or stomach
as become an accepted reconstructive option for patients with
ntractable incontinence and poor bladder compliance owing to
arious neurogenic and non-neurogenic disorders [2].
However, recently, there have been an increasing number of
eports of benign and malignant tumors developing in the neoblad-
er of post-ECP patients, particularly around the line of anastomosis
etween the colon cap and the native bladder remnant, which are
etected on long-term follow-up [2]. We  previously reported that
5 cases of malignancy occurring after ECP have been published
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in the literature [3]. Although N-nitrosamines were reported to
be associated with carcinogenesis following bladder augmentation,
the mechanisms involved remained unclear [4]. There are several
carcinogenic pathways associated with colorectal oncogenesis [5].
Adenomas that are greater than 1.0 cm in diameter, and with a
marked villous component have a high risk of developing into can-
cer [5]. Therefore, the early detection of adenomas is important
as it will enable early treatment, and therefore the prevention of
malignant changes.
We routinely perform annual surveillance cystoscopy in
patients who have undergone bladder augmentation in our depart-
ments. One such patient was found to have developed tubular
adenoma at the patch site of the sigmoid colon cap. The incidence
of adenoma after ECP is rare. To the best of our knowledge, there
are 11 cases of adenoma reported in the literature, including our
present case [4,6–14]. Here we report our rare case and review the
literature on cases of benign tumors that occurred after ECP.
up Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Cystoscopic ﬁndings before transurethral resection.
An image of the patient’s bladder. A 5-mm pedunculated polyp was  found on the
front side of the colon cap. There were no abnormalities in other areas of the bladder,
including in the anastomosis between the colon cap and the native bladder (arrows).
Fig. 2. Histopathological analysis of the tumor on biopsy.
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Fig. 3. Cystoscopic ﬁndings at the site of transurethral resection.
Image of the site of resection after snare polypectomy together with electrocoagu-
lation. No perforations or bleeding was detected.ematoxylin and eosin staining of the tumor specimen (× 40). The tumor was  con-
ained within the glandular component. No malignant changes were detected. The
iagnosis was tubular adenoma.
. Case report
A 23-year-old man  came to our hospital for routine surveillance
ystoscopy. He had no symptoms, such as upper tract infection,
ank pain, and hematuria. He was born with a lipomyelomeningo-
ele and neurogenic bladder with low bladder compliance. He
ad been undergoing clean intermittent catheterization and taking
nti-cholinergic agents since he was 3-years old. However, his neu-
ogenic bladder was unstable, and his bladder capacity decreased
nd his bladder compliance worsened. He hence underwent sig-
oidocolocystoplasty when he was 8-years old. His postoperative
ourse was stable, and his bladder capacity increased and his
rinary continence improved. The patient has been undergoing
nnual routine surveillance cystoscopy from 1 year after the blad-
er augmentation. The patient has no family history of bladder and
olorectal disease.
There were and no abnormalities on laboratory data before cys-
oscopy. Tumor markers, such as -fetoprotein, carcinoembryonic
ntigen, and carbohydrate antigen 19–9 were not increased.
Upon cystoscopy, there were no abnormalities around the anas-
omosis between the native bladder and sigmoid colon. However, 5-mm pedunculated polyp was found on the front side of the
igmoid colon cap, and hence we performed a biopsy (Fig. 1).
n histopathology, the polyp was identiﬁed as tubular adenoma
Fig. 2). Therefore, we performed snare polypectomy together withFig. 4. Histopathological analysis of the tumor on transurethral resection.
A  high magniﬁcation image of the tumor (× 400) showing the presence of glandular
epithelium. No malignant changes were detected.
electrocoagulation under cystoscopy (Fig. 3). The patient’s post-
operative course was  uneventful and his bladder function was
maintained. His bladder was drained for 24 h. His ﬁnal diagnosis
was tubular adenoma (mild atypia) and no malignancy was  found
on histopathology (Fig. 4a,b). We  performed routine annual surveil-
lance cystoscopy from 1 year after the polypectomy, because we
believe that the early diagnosis of adenoma will decrease the risk
of malignancy development. During the subsequent 5 years, there
has been no evidence of recurrence.
3. Discussion
Recent reports have suggested an increased incidence of malig-
nancy after ECP [2,15–18]. However, the incidence of adenoma
is rare. To the best of our knowledge, there have been 11 cases
of adenoma occurring after bladder augmentation reported in the
literature, including our present case [4,6–14] (Table 1). The sex dis-
tribution of the patients was  7 men  (64%) and 4 women (36%). The
age at ECP ranged from 5 to 50 years (mean: 27.1 years). The orig-
inal underlying disease was  urinary tuberculosis in 5 cases (45%),
neurogenic bladder in 3 cases (27%), rhabdomyosarcoma in 1 case
(9%), post bladder surgery complications in 1 case (9%), and detru-
sor instability in 1 case (9%). Symptoms included hematuria in 6
(55%), lumbar pain and oliguria in 1 (9%), frequent urination in 1
(9%), recurrent pyelonephritis in 1 (9%), and no symptoms (detected
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on a routine examination) in 1 (9%). Bladder augmentation involved
the colon in 7 cases (64%), small bowel in 3 cases (27%), and stomach
in 1 case (9%). Histopathology conﬁrmed tubulovillous adenoma in
4 cases (36%), villous adenoma in 3 cases (27%), tubular adenoma in
3 cases (27%), and adenocarcinoma in the tubulovillous adenoma in
1 case (9%). Adenoma arose from the anastomosis in 4 cases (36%),
intestinal cap in 6 cases (55%), and native bladder in 1 case (9%).
Treatment was  transurethral resection in 7 cases (64%), cystectomy
and ECP using other segments of the intestine in 2 cases (18%), and
partial resection in 2 cases (18%). There were 2 recurrent cases in
the literature [9,13].
The mechanism of colorectal cancer occurrence has been
analyzed in detail. There are at least 4 types of carcinogenic path-
ways that are associated with colorectal oncogenesis, namely, the
adenoma-carcinoma sequence type, the de novo type, the hered-
itary non-polyposis colorectal cancer type, and the colitic cancer
type [5]. Among these carcinogenic pathways, the de novo type and
the adenoma-carcinoma sequence type are thought to be particu-
larly important.
In the de novo type pathway, colorectal cancer develops directly
in the normal colorectal mucosa without adenoma. In the 1980s,
several Japanese researchers reported that they detected a ﬂat type
of carcinoma with a diameter of less than 10 mm arising de novo,
which tended to reach the deeper layers at an earlier stage than
polypoid-type carcinoma in adenoma [5].
In the adenoma-carcinoma sequence pathway, an adenoma ini-
tially forms and increases in size, and then a carcinoma forms in
the adenoma. This type of carcinogenesis is associated with several
genes, such as the adenomatous polyposis coli gene, K-ras gene,
p53 gene, and deleted in colorectal carcinoma gene. Adenomas
are well-demarcated lumps of epithelial tumor cells, which can be
classiﬁed into the following 3 major histological types: tubular, vil-
lous, and tubulovillous. The mechanism of the adenoma–carcinoma
sequence in colonic segments transposed to the urinary tract has
not been established, but may  be associated with chronic infec-
tion and inﬂammation, possibly via the reduction of urinary nitrites
to nitrates by bacteria, accompanied with the formation of N-
nitrosamines, which are potent carcinogens [4]. Adenomas that are
larger than 1.0 cm in diameter with a marked villous component
have the risk of developing into cancer [5]. Therefore, we  believe
that the early diagnosis of adenoma should decrease the risk of
malignancy development.
The use of routine surveillance cystoscopy and cytology is
controversial [19]. Higuchi et al. [20] reported that no tumors devel-
oped in their patients during a median surveillance time of 15 years
after ECP. Furthermore, they reported that they discontinued per-
forming annual surveillance endoscopy and cytology because of
the low incidence of malignancy, the lack of proven beneﬁt, and
for cost containment. Hamid et al. [21] also reported that it is not
necessary to perform annual check cystoscopies in patients with
augmented bladders at least for the ﬁrst 15 years after surgery.
However, they recommended that if the patient develops hema-
turia or other symptoms of concern, including suprapubic pain or
recurrent unexplained urinary tract infections, a full evaluation
including cystoscopy should be performed. Soergel et al. and Biers
et al. [16,17] recommended that routine cystoscopic surveillance of
all patients with a history of bladder augmentation should be per-
formed from 10 years after the initial surgery. On the other hand,
Lin et al. [14] recommended that long-term active surveillance is
necessary for all patients who undergo gastrocystoplasty, because
they encountered an extremely rare case of a tubulovillous ade-
noma that transformed into adenocarcinoma in the native bladder
segment of an augmented bladder 9 years after surgery. We  also
perform annual cystoscopic evaluations and cytological examina-
tions in patients after bladder augmentation in our departments.
We encountered 1 case of sarcoma occurring 13 years after bladder
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ugmentation [3], and 1 case of adenoma occurring 15 years after
ladder augmentation. Most cases of malignancy occur more than
0 years after bladder augmentation. However, some cases occur
ithin 10 years after bladder augmentation [3]. We  cannot predict
he time of occurrence of malignancy. Therefore, we believe that
he early detection of carcinoma or adenoma should lead to their
uccessful treatment. We  also recommend routine annual routine
ystoscopy from 1year after bladder augmentation, because the
ladder mucosa can be directly examined by this technique.
. Conclusions
We  reported a rare case of adenoma developing after sig-
oidocolocystoplasty. We  recommend performing routine annual
urveillance in patients with bladder augmentation for the early
etection of tumors.
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